Search





Search





Markets
/
Stocks
/
bngo
/

Bionano Genomics Inc

BNGO

Add to Watchlist

1.070USD

+0.010+0.94%

Close 07-31 16:00（ET）Quotes delayed by 15 min

11.49MMarket Cap

LossP/E TTM

Bionano Genomics Inc

1.070

+0.010+0.94%

Financial Summary Income Statement Balance Sheet Cash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial Summary Income Statement Balance Sheet Cash Flow Statement

BNGO Cash Flow Statement

You can access the annual and quarterly cash flow statements of Bionano Genomics Inc to evaluate its financial soundness and stability.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2020Q2

FY2020Q1

FY2019Q4

FY2019Q3

FY2019Q2

FY2019Q1

FY2018Q4

FY2018Q3

FY2018Q2

FY2018Q1

FY2017Q4

FY2017Q3

FY2017Q2

FY2017Q1

Operating cash flows (indirect method)

Cash flow from continuing operating activities

-106.80%-5.72M

35.81%-4.17M

55.53%-5.92M

83.38%-3.49M

90.17%-2.76M

78.16%-6.50M

49.38%-13.31M

42.83%-20.98M

13.21%-28.13M

13.73%-29.78M

10.79%-26.29M

-29.52%-36.70M

0.25%-32.41M

-34.72%-34.52M

-47.50%-29.47M

-128.13%-28.33M

-133.70%-32.49M

-111.68%-25.62M

-82.32%-19.98M

-72.06%-12.42M

-73.11%-13.90M

-27.46%-12.10M

-52.72%-10.96M

-14.26%-7.22M

-22.59%-8.03M

-132.18%-9.50M

-17.66%-7.18M

-112.95%-6.32M

3.47%-6.55M

-45.61%-4.09M

-7.86%-6.10M

40.53%-2.97M

7.85%-6.79M

---2.81M

---5.66M

---4.99M

---7.37M

Net income from continuing operations

-167.67%-8.30M

60.58%-7.93M

80.78%-8.50M

57.74%-6.86M

90.13%-3.10M

54.15%-20.13M

60.69%-44.25M

58.31%-16.22M

15.36%-31.42M

-13.48%-43.89M

-253.90%-112.56M

-21.00%-38.91M

-23.94%-37.12M

-68.53%-38.68M

-53.26%-31.81M

-71.19%-32.16M

-201.12%-29.95M

-95.64%-22.95M

-92.30%-20.75M

-132.67%-18.79M

5.36%-9.95M

-48.47%-11.73M

-68.67%-10.79M

-5.34%-8.07M

-33.85%-10.51M

-23.23%-7.90M

-29.88%-6.40M

-131.45%-7.66M

-104.09%-7.85M

-8.30%-6.41M

3.13%-4.93M

50.39%-3.31M

32.33%-3.85M

---5.92M

---5.09M

---6.67M

---5.69M

Operating gains losses

-4.99%2.36M

-31.24%2.39M

-92.51%2.43M

-20.01%2.43M

-29.12%2.48M

-4.77%3.47M

-59.96%32.41M

-9.23%3.04M

8.18%3.51M

29.46%3.65M

3230.15%80.96M

42.29%3.35M

44.75%3.24M

49.84%2.82M

362.17%2.43M

356.01%2.35M

399.78%2.24M

229.82%1.88M

65.41%526.00K

74.92%516.00K

51.35%448.00K

82.19%570.00K

14.31%318.00K

10.50%295.00K

9.63%296.00K

107.58%312.87K

-28.90%278.18K

-31.04%266.96K

-31.03%270.00K

-86.82%150.72K

62.65%391.25K

4.19%387.10K

10.94%391.45K

--1.14M

--240.55K

--371.54K

--352.84K

Deferred tax

----

130.47%1.76M

----

---5.78M

----

Other non-cash items

102.61%151.00K

-96.98%180.00K

271.97%227.00K

123.22%382.00K

29.35%-5.78M

-65.67%5.95M

-103.08%-132.00K

-594.09%-1.65M

-6970.59%-8.18M

2550.31%17.33M

-129.15%-65.00K

-147.98%-237.00K

-80.10%119.00K

115.84%654.00K

208.78%223.00K

-76.96%494.00K

140.96%598.00K

-66.81%303.00K

-159.42%-205.00K

254.97%2.14M

-209.20%-1.46M

-0.16%913.00K

50.91%345.00K

145.62%604.00K

-3.26%1.34M

306.42%914.48K

134.03%228.62K

127.38%245.91K

248.30%1.38M

-65.32%225.01K

-405.47%-671.83K

-895.97%-898.23K

-41.70%-931.87K

--648.76K

---132.91K

--112.85K

---657.62K

Change in working capital

-131.09%-629.00K

-88.34%264.00K

-184.38%-1.01M

82.50%-763.00K

-61.83%2.02M

136.24%2.27M

11.04%1.20M

30.45%-4.36M

259.30%5.30M

6.65%-6.25M

116.69%1.08M

-28.64%-6.27M

68.49%-3.33M

-69.62%-6.70M

-176.26%-6.46M

-350.08%-4.87M

-218.46%-10.56M

-71.01%-3.95M

-82.94%-2.34M

625.34%1.95M

-741.39%-3.32M

24.99%-2.31M

22.54%-1.28M

-193.67%-371.00K

180.66%517.00K

-1447.78%-3.08M

-74.37%-1.65M

-50.69%396.09K

73.88%-641.00K

-80.61%228.29K

-34.87%-946.20K

-27.43%803.20K

-63.85%-2.45M

--1.18M

---701.59K

--1.11M

---1.50M

-Change in receivables

-23.68%1.07M

-606.77%-674.00K

-209.45%-1.03M

-106.84%-141.00K

39.24%1.40M

120.46%133.00K

189.20%942.00K

347.60%2.06M

314.88%1.00M

62.49%-650.00K

11.34%-1.06M

-225.30%-832.00K

137.81%242.00K

-1003.82%-1.73M

-336.26%-1.19M

178.49%664.00K

-181.74%-640.00K

-141.53%-157.00K

-217.44%-273.00K

-258.43%-846.00K

-37.91%783.00K

142.57%378.00K

91.55%-86.00K

157.64%534.00K

175.93%1.26M

-72.97%-888.05K

-65.49%-1.02M

-57.46%-926.38K

-44.02%457.00K

52.24%-513.41K

47.12%-614.72K

-280.77%-588.31K

465.20%816.32K

---1.08M

---1.16M

--325.44K

--144.43K

-Change in inventory

-109.55%-106.00K

-46.35%1.57M

161.60%1.51M

182.93%724.00K

655.00%1.11M

986.40%2.93M

-169.43%-2.45M

46.70%-873.00K

96.50%-200.00K

94.04%-331.00K

158.51%3.53M

73.40%-1.64M

3.89%-5.71M

0.48%-5.55M

10.61%-6.03M

-132.87%-6.16M

-517.90%-5.94M

-847.71%-5.58M

-161.79%-6.74M

-557.71%-2.64M

-51.34%-961.00K

66.44%-589.00K

-3917.64%-2.58M

75.13%-402.00K

-88.43%-635.00K

-204.31%-1.75M

103.50%67.45K

-1193.68%-1.62M

-5.19%-337.00K

1475.30%1.68M

-965.00%-1.93M

146.94%147.78K

8.73%-320.36K

--106.80K

--222.99K

---314.83K

---351.01K

-Change in prepaid expenses

358.11%339.00K

-86.09%173.00K

-188.61%-2.28M

-151.79%-29.00K

-93.10%74.00K

863.19%1.24M

-93.15%-790.00K

-95.74%56.00K

127.81%1.07M

-167.36%-163.00K

88.72%-409.00K

135.91%1.31M

226.95%471.00K

139.60%242.00K

-46.64%-3.63M

-61.56%557.00K

64.63%-371.00K

123.33%101.00K

-205.19%-2.47M

658.64%1.45M

-2079.25%-1.05M

-26.18%-433.00K

-327.34%-810.00K

-82.46%191.00K

106.62%53.00K

-180.12%-343.15K

-145.01%-189.54K

4713.81%1.09M

-18.89%-801.00K

-19.12%428.27K

-31.24%421.10K

-126.01%-23.60K

-45.80%-673.76K

--529.52K

--612.42K

--90.73K

---462.12K

-Change in other current assets

-95.15%16.00K

-93300.00%-932.00K

-89.59%326.00K

-55.73%336.00K

-58.02%330.00K

-99.96%1.00K

143.43%3.13M

453.02%759.00K

311.29%786.00K

345.84%2.78M

---7.21M

---215.00K

---372.00K

---1.13M

----

Cash from non-recurring investing activities

Cash from operating activities

-106.80%-5.72M

35.81%-4.17M

55.53%-5.92M

83.38%-3.49M

90.17%-2.76M

78.16%-6.50M

49.38%-13.31M

42.83%-20.98M

13.21%-28.13M

13.73%-29.78M

10.79%-26.29M

-29.52%-36.70M

0.25%-32.41M

-34.72%-34.52M

-47.50%-29.47M

-128.13%-28.33M

-133.70%-32.49M

-111.68%-25.62M

-82.32%-19.98M

-72.06%-12.42M

-73.11%-13.90M

-27.46%-12.10M

-52.72%-10.96M

-14.26%-7.22M

-22.59%-8.03M

-132.18%-9.50M

-17.66%-7.18M

-112.95%-6.32M

3.47%-6.55M

-45.61%-4.09M

-7.86%-6.10M

40.53%-2.97M

7.85%-6.79M

---2.81M

---5.66M

---4.99M

---7.37M

Investing cash flow

Net cash from continuing investing activities

----

--0.00

-100.00%0.00

-84.93%77.00K

-92.78%26.00K

11.69%745.00K

-74.23%75.00K

8.96%511.00K

-62.30%360.00K

10.43%667.00K

8.58%291.00K

733.78%469.00K

3879.17%955.00K

--604.00K

--268.00K

---74.00K

--24.00K

-100.00%0.00

----

91.58%22.67K

-93.30%8.74K

-83.30%29.65K

----

-95.80%11.83K

-52.40%130.48K

-54.52%177.57K

-83.46%11.83K

--281.77K

--274.12K

--390.41K

--71.53K

Capital expenditures

----

--0.00

-100.00%0.00

-84.93%77.00K

-92.78%26.00K

-45.98%745.00K

-84.38%107.00K

8.96%511.00K

-63.34%360.00K

128.31%1.38M

155.60%685.00K

801.92%469.00K

3991.67%982.00K

--604.00K

--268.00K

--52.00K

--24.00K

-100.00%0.00

----

91.58%22.67K

-93.30%8.74K

-83.30%29.65K

----

-95.80%11.83K

-52.40%130.48K

-54.52%177.57K

-83.46%11.83K

--281.77K

--274.12K

--390.41K

--71.53K

Net cash flow from disposal of fixed assets

----

--0.00

-100.00%0.00

-84.93%77.00K

-92.78%26.00K

11.69%745.00K

-74.23%75.00K

8.96%511.00K

-62.30%360.00K

10.43%667.00K

8.58%291.00K

733.78%469.00K

3879.17%955.00K

--604.00K

--268.00K

---74.00K

--24.00K

-100.00%0.00

----

91.58%22.67K

-93.30%8.74K

-83.30%29.65K

----

-95.80%11.83K

-52.40%130.48K

-54.52%177.57K

-83.46%11.83K

--281.77K

--274.12K

--390.41K

--71.53K

Net cash flow from business transactions

----

--0.00

----

100.00%0.00

--0.00

--96.00K

-100.00%0.00

36.14%-31.34M

--0.00

--694.00K

---49.09M

----

--0.00

---2.45M

----

Net cash flow from investment products

138.80%5.46M

33.77%4.01M

13.13%-4.67M

-93.11%1.98M

-129.54%-14.07M

105.49%3.00M

-116.04%-5.38M

-4.28%28.71M

181.93%47.61M

-222.72%-54.63M

306.38%33.50M

-5.42%29.99M

-47.59%16.89M

207.07%44.52M

104.45%8.24M

--31.71M

--32.23M

---41.58M

---185.33M

----

Net cash flow from other investing activities

----

--0.00

----

--0.00

----

28.19%-894.00K

----

---1.25M

----

Cash from non-current investing activities

Net cash flow from investing activities

138.80%5.46M

33.77%4.01M

13.13%-4.67M

-93.09%1.98M

-129.56%-14.07M

105.41%3.00M

-116.08%-5.38M

-3.20%28.63M

187.91%47.59M

-576.94%-55.37M

320.31%33.43M

-5.33%29.58M

-48.29%16.53M

112.55%11.61M

104.28%7.95M

42116.22%31.24M

133283.33%31.96M

---92.51M

-7475.59%-185.60M

--74.00K

---24.00K

100.00%0.00

-27928.83%-2.45M

----

-91.58%-22.67K

93.30%-8.74K

83.30%-29.65K

----

95.80%-11.83K

52.40%-130.48K

54.52%-177.57K

83.46%-11.83K

---281.77K

---274.12K

---390.41K

---71.53K

Financing cash flow

Cash flow from continuous financing activities

-93.97%657.00K

-58.79%1.60M

67.35%10.08M

174.27%1.47M

150.38%10.89M

-94.32%3.89M

-52.17%6.02M

-111.06%-1.98M

-245.46%-21.62M

46806.85%68.48M

-44.43%12.59M

8708.37%17.88M

212214.29%14.86M

-92.58%146.00K

64.54%22.65M

101.18%203.00K

-100.00%7.00K

-93.79%1.97M

-8.73%13.77M

-205.47%-17.16M

29838.85%337.54M

70.41%31.69M

12927.41%15.08M

1906.17%16.27M

-110.45%-1.14M

57646.25%18.59M

-99.40%115.78K

-74.78%810.90K

-18.54%10.86M

-102.19%-32.31K

563.98%19.26M

-48.61%3.22M

91.11%13.33M

--1.47M

--2.90M

--6.26M

--6.98M

Net cash flow from debt Issuance/repayment

98.68%-20.00K

99.11%-18.00K

37.18%-1.89M

76.10%-1.52M

95.87%-1.52M

-102.84%-2.02M

-25025.00%-3.02M

-52833.33%-6.35M

-366670.00%-36.68M

709970.00%70.99M

-33.33%-12.00K

-25.00%-10.00K

-100.50%-10.00K

---9.00K

99.95%-9.00K

---8.00K

200600.00%2.00M

-100.00%0.00

-1285.18%-17.01M

100.00%0.00

-100.20%-1.00K

-99.14%1.00K

-253.54%-1.23M

-141.63%-3.50M

1676.50%509.38K

189.42%115.78K

-75.12%799.82K

-37.02%8.39M

---32.31K

---129.47K

--3.21M

--13.33M

--0.00

Net cash flow from common stock issuance/repurchase

-94.71%705.00K

-73.95%1.75M

27.98%12.94M

-74.57%3.09M

-13.78%13.32M

-40.45%6.72M

-21.77%10.11M

-33.42%12.16M

1.42%15.45M

--11.29M

-44.12%12.92M

--18.26M

--15.23M

----

64.30%23.13M

--0.00

-100.00%0.00

-99.63%88.00K

--14.08M

-100.00%0.00

--328.63M

37.68%23.61M

--0.00

--16.37M

-100.00%0.00

--17.15M

-100.00%0.00

--0.00

--2.41M

--0.00

--19.39M

----

Net cash flow from preferred stock issuance/repurchase

----

-100.00%0.00

----

-100.00%0.00

--1.46M

--2.90M

--6.26M

--6.98M

Proceeds from stock option exercised by employees

-100.00%0.00

--0.00

-100.00%0.00

--9.00K

--0.00

--2.00K

-100.00%0.00

53.33%23.00K

232.79%81.00K

-54.92%110.00K

23.42%137.00K

-99.85%15.00K

-100.60%-61.00K

-98.38%244.00K

-89.99%111.00K

312.12%9.73M

1169.15%10.10M

--15.08M

9905.41%1.11M

4270.37%2.36M

--795.81K

-100.00%0.00

1467.75%11.08K

17604.92%54.00K

-100.00%0.00

65.80%2.49K

--707.00

--305.00

--12.79K

--1.50K

--0.00

Net cash flow from other financing activities

96.95%-28.00K

84.07%-130.00K

9.94%-969.00K

98.66%-104.00K

-138.08%-919.00K

94.08%-816.00K

-232.10%-1.08M

-2032.88%-7.79M

-1.58%-386.00K

-18485.33%-13.79M

43.94%-324.00K

-586.67%-365.00K

---380.00K

215.38%75.00K

-4.14%-578.00K

128.96%75.00K

100.00%0.00

96.78%-65.00K

---555.00K

-1333.33%-259.00K

---825.00K

-1526.19%-2.02M

--0.00

--21.00K

----

--141.71K

----

Net cash from non-recurrent financing activities

Net cash from financing activities

-93.97%657.00K

-58.79%1.60M

67.35%10.08M

174.27%1.47M

150.38%10.89M

-94.32%3.89M

-52.17%6.02M

-111.06%-1.98M

-245.46%-21.62M

46806.85%68.48M

-44.43%12.59M

8708.37%17.88M

212214.29%14.86M

-92.58%146.00K

64.54%22.65M

101.18%203.00K

-100.00%7.00K

-93.79%1.97M

-8.73%13.77M

-205.47%-17.16M

29838.85%337.54M

70.41%31.69M

12927.41%15.08M

1906.17%16.27M

-110.45%-1.14M

57646.25%18.59M

-99.40%115.78K

-74.78%810.90K

-18.54%10.86M

-102.19%-32.31K

563.98%19.26M

-48.61%3.22M

91.11%13.33M

--1.47M

--2.90M

--6.26M

--6.98M

Net cash flow

Beginning cash balance

-52.90%4.51M

-66.66%3.06M

-83.69%3.56M

-77.57%3.63M

-47.83%9.57M

-73.71%9.19M

43.11%21.83M

258.77%16.16M

234.15%18.35M

24.15%34.97M

-43.83%15.26M

-81.27%4.50M

-77.65%5.49M

-79.99%28.17M

-91.83%27.16M

-93.36%24.05M

-36.09%24.57M

645.94%140.74M

1834.13%332.55M

4345.69%362.06M

122.11%38.45M

129.39%18.87M

12.42%17.19M

-60.90%8.14M

4.77%17.31M

-60.18%8.22M

100.60%15.29M

175.80%20.83M

1516.89%16.52M

683.05%20.66M

34.56%7.62M

57.76%7.55M

-80.53%1.02M

--2.64M

--5.67M

--4.79M

--5.25M

Current period cash flow changes

106.78%403.00K

281.00%1.44M

96.07%-497.00K

-101.11%-63.00K

-171.72%-5.95M

102.28%379.00K

-164.12%-12.64M

-47.23%5.67M

-121.78%-2.19M

26.70%-16.62M

1857.50%19.71M

245.61%10.75M

-88.72%-987.00K

80.48%-22.68M

100.52%1.01M

110.54%3.11M

-100.16%-523.00K

-693.22%-116.17M

-11565.51%-191.82M

-426.00%-29.50M

3630.14%323.61M

115.50%19.58M

123.66%1.67M

263.48%9.05M

-312.84%-9.17M

319.78%9.09M

-154.25%-7.07M

-7834.58%-5.54M

-34.05%4.31M

-155.81%-4.13M

530.37%13.03M

-91.85%71.57K

1513.48%6.53M

---1.62M

---3.03M

--878.71K

---462.04K

Effect of exchange rate changes

155.56%5.00K

275.00%7.00K

-37.50%15.00K

-2300.00%-24.00K

65.38%-9.00K

-108.33%-4.00K

340.00%24.00K

88.89%-1.00K

-172.22%-26.00K

-44.19%48.00K

91.94%-10.00K

---9.00K

--36.00K

--86.00K

---124.00K

----

Ending cash balance

35.50%4.91M

-52.90%4.51M

-66.66%3.06M

-83.69%3.56M

-77.57%3.63M

-47.83%9.57M

-73.71%9.19M

43.11%21.83M

258.77%16.16M

234.15%18.35M

24.15%34.97M

-43.83%15.26M

-81.27%4.50M

-77.65%5.49M

-79.99%28.17M

-91.83%27.16M

-93.36%24.05M

-36.09%24.57M

645.94%140.74M

1834.13%332.55M

4345.69%362.06M

122.10%38.45M

129.39%18.87M

12.42%17.19M

-60.90%8.14M

4.77%17.31M

-60.18%8.22M

100.60%15.29M

175.79%20.83M

1516.87%16.52M

683.05%20.66M

34.56%7.62M

57.76%7.55M

--1.02M

--2.64M

--5.67M

--4.79M

Free cash flow

-106.80%-5.72M

35.81%-4.17M

55.53%-5.92M

83.44%-3.49M

90.18%-2.76M

78.69%-6.50M

49.59%-13.31M

43.41%-21.05M

14.08%-28.16M

14.97%-30.52M

12.46%-26.40M

-29.19%-37.21M

2.10%-32.77M

-36.87%-35.90M

-48.93%-30.16M

-130.94%-28.80M

-140.35%-33.48M

-116.67%-26.23M

-84.76%-20.25M

---12.47M

---13.93M

-27.15%-12.10M

-52.53%-10.96M

----

-132.06%-9.52M

-15.33%-7.19M

-101.87%-6.35M

----

-32.72%-4.10M

-5.07%-6.23M

41.54%-3.14M

8.58%-6.80M

---3.09M

---5.93M

---5.38M

---7.44M

Currency unit

--USD

Audit opinions

----

FAQs

What is operating cash flow?



Operating cash flow is the cash generated or used by a company's core business operations. It adjusts net income for non-cash items and working capital changes, such as depreciation, receivables, inventory, and payables. Strong operating cash flow can indicate that the business is converting sales and earnings into real cash.

How Much Operating Cash Flow Did Bionano Genomics Inc Generate?



Bionano Genomics Inc generated -16.34M in operating cash flow in fiscal 2025, reflecting cash generated from its core business operations.

How Did Bionano Genomics Inc's Operating Cash Flow Change Year Over Year?



Bionano Genomics Inc's operating cash flow increased by 76.28% year over year.

What is investing cash flow?



Investing cash flow shows cash used for or generated from investment-related activities, such as capital expenditures, purchases or sales of investments, acquisitions, and asset disposals. Negative investing cash flow is not always bad, because it can reflect spending on future growth, but investors should check whether those investments support long-term returns.

What is financing cash flow?



Financing cash flow shows how a company raises capital or returns capital to investors and creditors. It can include debt issuance, debt repayment, share issuance, share repurchases, dividend payments, and lease financing. Positive financing cash flow may show new capital raised, while negative financing cash flow may reflect debt repayment, dividends, or buybacks.

How Has Bionano Genomics Inc's Financing Cash Flow Changed?



Bionano Genomics Inc used 24.04M in financing activities in the latest quarter.

What is free cash flow and why does it matter for BNGO?



Free cash flow is the cash a company has left after funding the capital spending needed to maintain or grow the business. It is often used to assess financial flexibility, debt repayment capacity, dividend sustainability, buyback potential, and valuation quality. Investors should compare free cash flow with net income, revenue growth, and capital expenditures.

What was Bionano Genomics Inc’s free cash flow in the latest quarter?



Free cash flow was -16.34M reflecting a 76.32% change from the previous year.